Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
Titel:
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
Auteur:
Montalban, Xavier Vermersch, Patrick Arnold, Douglas L Bar-Or, Amit Cree, Bruce A C Cross, Anne H Kubala Havrdova, Eva Kappos, Ludwig Stuve, Olaf Wiendl, Heinz Wolinsky, Jerry S Dahlke, Frank Le Bolay, Claire Shen Loo, Li Gopalakrishnan, Sathej Hyvert, Yann Javor, Andrija Guehring, Hans Tenenbaum, Nadia Tomic, Davorka